Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis

Details for Australian Patent Application No. 2002218461 (hide)

Owner Vascular Biogenics Ltd

Inventors Harats, Dror; Halperin, Gideon; George, Jacob

Agent Cullen & Co

Pub. Number AU-B-2002218461

PCT Pub. Number WO02/41827

Priority 60/252,574 24.11.00 US

Filing date 22 November 2001

Wipo publication date 3 June 2002

Acceptance publication date 7 September 2006

International Classifications

A61K 31/685 (2006.01)

A61K 31/075 (2006.01) - Ethers or acetals

A61K 31/08 (2006.01)

A61K 31/11 (2006.01) - Aldehydes

A61K 31/19 (2006.01)

A61K 31/20 (2006.01)

A61K 31/215 (2006.01)

A61K 31/24 (2006.01)

C07C 43/178 (2006.01) Ethers

C07F 9/10 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

Event Publications

7 September 2006 Application Accepted

  Published as AU-B-2002218461

24 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002218462

2002218460